Elstar raises $39M series A

Elstar Therapeutics Inc. (Cambridge, Mass.) raised $39 million in a series A round from Apple Tree Partners.

The company is using its Universal Targeted Immunotherapy (UniTI) platform to rapidly generate antibody-based, multi-functional therapeutics for cancer...